{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:04:39Z","timestamp":1775556279455,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajo.2022.03.010","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T20:29:10Z","timestamp":1647030550000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Time Trends of Etiologies of Blindness in Israel 2009-2020:Have Methods to Decrease Leading Causes of Blindness Been Exhausted?"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0096-880X","authenticated-orcid":false,"given":"Asaf","family":"Israeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Peer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Gleitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishay","family":"Falick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-7538","authenticated-orcid":false,"given":"Eedy","family":"Mezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2022.03.010_bib0001","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.122.4.615","article-title":"VISION 2020: The right to sight -a global initiative to eliminate avoidable blindness","volume":"122","author":"Pizzarello","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"30","key":"10.1016\/j.ajo.2022.03.010_bib0002","first-page":"32","article-title":"The global initiative for the elimination of avoidable blindness - vision 2020: the right to sight","volume":"12","author":"McGavin","year":"1999","journal-title":"Community Eye Heal"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0003","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1120672118819397","article-title":"Preventing blindness and visual impairment in Europe: what do we have to do?","volume":"29","author":"N\u00e9meth","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0004","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Adelson","year":"2021","journal-title":"Lancet Glob Heal"},{"issue":"11","key":"10.1016\/j.ajo.2022.03.010_bib0005","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0006","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","author":"Bourne","year":"2021","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.ajo.2022.03.010_bib0007","unstructured":"World Health Organization. Global initiative for the elimination of avoidable blindnessaction plan 2006\u20132011. 2007. http:\/\/www.who.int\/iris\/handle\/10665\/43754, Accessed- March 2nd, 2022."},{"issue":"3","key":"10.1016\/j.ajo.2022.03.010_bib0008","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bjo.2005.080986","article-title":"The economic impact and cost of visual impairment in Australia","volume":"90","author":"Taylor","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.03.010_bib0009","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1076\/opep.10.4.267.15910","article-title":"National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness","volume":"10","author":"Farber","year":"2003","journal-title":"Ophthalmic Epidemiol"},{"issue":"11","key":"10.1016\/j.ajo.2022.03.010_bib0010","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/eye.2010.122","article-title":"Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008","volume":"24","author":"Bunce","year":"2010","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.ajo.2022.03.010_bib0011","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1167\/iovs.02-0304","article-title":"Incidence of blindness in Southern Germany due to glaucoma and degenerative conditions","volume":"44","author":"Trautner","year":"2003","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2022.03.010_bib0012","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1475-1313.2011.00849.x","article-title":"Glaucoma blind registration in Fife (2000-2009)-a retrospective cohort study","volume":"31","author":"O'Colmain","year":"2011","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.010_bib0013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09286580500473779","article-title":"Trends in registered blindness and its causes over 19 years in Western Australia","volume":"13","author":"Yong","year":"2006","journal-title":"Ophthalmic Epidemiol"},{"issue":"9393","key":"10.1016\/j.ajo.2022.03.010_bib0014","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(03)14631-4","article-title":"Severe visual impairment and blindness in children in the UK","volume":"362","author":"Rahi","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajo.2011.08.035","article-title":"Time trends in the incidence and causes of blindness in Israel","volume":"153","author":"Skaat","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.010_bib0016","unstructured":"Population in Localities, Central Bureau of Statistics, Jerusalem, Israel. https:\/\/www.cbs.gov.il\/he\/subjects\/Pages\/\u05d0\u05d5\u05db\u05dc\u05d5\u05e1\u05d9\u05d9\u05d4-\u05d1\u05d9\u05d9\u05e9\u05d5\u05d1\u05d9\u05dd.aspx#, Accessed- August 27th, 2021."},{"issue":"3","key":"10.1016\/j.ajo.2022.03.010_bib0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaapos.2015.04.002","article-title":"Trends in the incidence and causes of severe visual impairment and blindness in children from Israel","volume":"19","author":"Mezer","year":"2015","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2022.03.010_bib0018","unstructured":"Escort Fee for People with Visual Impairments. Israel: Social work regulations; 2015. https:\/\/www.molsa.gov.il\/CommunityInfo\/Regulations\/SocialRegulations\/Documents\/\u05e4\u05e8\u05e7 6- \u05d8\u05d9\u05e4\u05d5\u05dc \u05d1\u05e2\u05d9\u05d5\u05d5\u05e8\u05d9\u05dd\/6.1.pdf, Accessed- August 27th, 2021."},{"issue":"12","key":"10.1016\/j.ajo.2022.03.010_bib0019","first-page":"FC40","article-title":"A study of medication compliance in geriatric patients with chronic illnesses at a tertiary care hospital","volume":"10","author":"Shruthi","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0020","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Heal"},{"issue":"5","key":"10.1016\/j.ajo.2022.03.010_bib0021","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/APO.0000000000000415","article-title":"Incidence of newly registered blindness from age-related macular degeneration in australia over a 21-year period: 1996-2016","volume":"10","author":"Heath Jeffery","year":"2021","journal-title":"Asia-Pacific J Ophthalmol (Philadelphia, Pa)"},{"issue":"7","key":"10.1016\/j.ajo.2022.03.010_bib0022","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41433-020-0864-6","article-title":"Recent trends in vision impairment certifications in England and Wales","volume":"34","author":"Rahman","year":"2020","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.ajo.2022.03.010_bib0023","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4103\/ijo.IJO_910_17","article-title":"Community care for diabetic retinopathy and glaucoma in India: a panel discussion","volume":"66","author":"Rani","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.03.010_bib0024","first-page":"1909","article-title":"Smartphones, tele-ophthalmology, and VISION 2020","volume":"10","author":"Mohammadpour","year":"2017","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICU.0000000000000552","article-title":"Artificial intelligence in glaucoma","volume":"30","author":"Zheng","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.03.010_bib0026","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2337\/dc09-0615","article-title":"Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis","volume":"32","author":"Wong","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajo.2022.03.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107840","article-title":"IDF Diabetes atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018","volume":"157","author":"Thomas","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.ajo.2022.03.010_bib0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09286586.2016.1259638","article-title":"Mini Review: Changes in the incidence of and progression to proliferative and sight-threatening diabetic retinopathy over the last 30 years","volume":"24","author":"Liew","year":"2017","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"10.1016\/j.ajo.2022.03.010_bib0029","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09286586.2016.1193618","article-title":"Ten emerging trends in the epidemiology of diabetic retinopathy","volume":"23","author":"Sabanayagam","year":"2016","journal-title":"Ophthalmic Epidemiol"},{"issue":"10","key":"10.1016\/j.ajo.2022.03.010_bib0030","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ophtha.2008.08.012","article-title":"Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology","volume":"115","author":"Ip","year":"2008","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.ajo.2022.03.010_bib0031","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Research Group","year":"2011","journal-title":"N Engl J Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:50:52Z","timestamp":1757598652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":31,"alternative-id":["S0002939422001040"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.03.010","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time Trends of Etiologies of Blindness in Israel 2009-2020:Have Methods to Decrease Leading Causes of Blindness Been Exhausted?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}